•
Jun 30, 2018

Edwards Lifesciences Q2 2018 Earnings Report

Total Revenue
$944M
Previous year: $842M
+12.1%
EPS
$0.41
Previous year: $0.36
+13.9%
Gross Profit
$698M
Previous year: $631M
+10.6%
Cash and Equivalents
$1.23B
Previous year: $508M
+141.3%
Free Cash Flow
$87.4M
Previous year: $140M
-37.4%
Total Assets
$5.69B
Previous year: $5.14B
+10.7%

Edwards Lifesciences

Edwards Lifesciences